Genmab — April 2019

[E_L]

CT080/ 4- Melflufen and dexamethasone (dex) plus bortezomib (BTZ) or daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) (OP-104) https://www.abstractsonline.com/pp8/#!/6812/presentation/9888

[E_L]

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia (CLL) http://clincancerres.aacrjournals.org/content/early/2019/04/02/1078-0432.CCR-18-3412

[E_L]

Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 146,961 shares as a consequence of the exercise of employee warrants.

[bibob]

https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=83960408-e371-4017-b4e9-7ca7486f13c5&atid=337668

[bibob]

Yes E L. Still a lot of cheap shares left. https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=26de526d-86f6-4fca-92c3-759c24e04646&atid=337664

[Bulder]

det var godt nok mange. Hvis de skal sælges i morgen, ser det rødt ud.

[Solsen]

Så køber vi flere. Mange gør stærk

[E_L]

so most of them were management and sold today, about 2/3

[Solsen]

I dont se that they are sold ?

[Bulder]

Neither do I. Danske hardly sold any - only 8k

[peter12]

If they believe in Maia they will wait ?

[E_L]

my mistake, i thought the link from bibob were sales, but it was Subscription, sry.

[Bulder]

Well, management was 102,650 shares. Maybe they'll keep them.

[E_L]

@peter12 some may not have enough cash to wait ; they will need to pay for the shares and for taxes , so they may be forced to sell to fund that

[bibob]

New questions about the tradeoffs in ‘accelerated’ cancer drug studies

Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds.

OHSU News (news.ohsu.edu)

[Bulder]

Ikke ringe, hvis man kunne købe 45k aktier til 80 kr stykket.

[bibob]

Genmab igen på Børsen. https://borsen.dk/nyheder/avisen/artikel/11/222471/artikel.html?utm_source=forside&utm_campaign=nyhed_01

[JKY_VH]

tak for den bibob;-)

[Sukkeralf]

Hvad står der i den bibob?

[bibob]

Har desværre ikke adgang, men flot overskrift.